MedPath

Mapping short-term brain changes in cannabis users

Not Applicable
Completed
Conditions
Moderate-to-severe Cannabis Use Disorder (CUD), as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Mental and Behavioural Disorders
Mental and behavioural disorders due to use of cannabinoids
Registration Number
ISRCTN76056942
Lead Sponsor
Australian Catholic University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
116
Inclusion Criteria

Inclusion criteria for all participants:
1. Aged 18 to 55 years
2. Normal-to-corrected vision
3. Fluent in English
4. Meeting safety criteria for MRI scan

Inclusion criteria for cannabis users:
1. Daily/almost daily (>3 days per week) cannabis use for >12 months
2. CUD 4+ DSM-5 symptoms
3. Tried to quit/reduce cannabis use at least once within the past 24 months

Exclusion Criteria

Exclusion criteria for all participants:
1. Any illicit substance and alcohol use for 12 hours before assessment (confirmed by self- report)
2. Currently using prescription medication that affect the central nervous system
3. Current or past diagnosed psychiatric disorders
4. Any current severe psychiatric diagnosis, excepting diagnoses of depression or anxiety
5. History of any neurological disorders
6. History of acquired or traumatic brain injury
7. Currently pregnant
8. Suicidality

Exclusion criteria for cannabis users:
1. Significant use or dependence on alcohol and any illicit substances other than cannabis
2. Illicit drug use past 4 weeks (other than cannabis)

Exclusion criteria for non-cannabis using controls:
1. Significant use or dependence on alcohol and any illicit substances
2. Illicit drug use past 4 weeks

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath